Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Defense Commission Reform topic

No spam. Unsubscribe anytime.

Committee Accepts Substitute to HB 292, Renaming Defense Commission and Adjusting Membership

House Veterans and Military Development Committee · February 18, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

The committee accepted a substitute for House Bill 292 that clarifies commission composition, adds regional and industry representation, specifies nonvoting members, and renames the Defense Commission to the Ohio Defense and Space Commission; the substitute was adopted without objection.

The Veterans and Military Development Committee adopted a substitute to House Bill 292 during its fourth hearing, updating the commission’s composition and renaming the body the "Ohio Defense and Space Commission." Vice Chair Matthews moved the substitute bill and described it as a set of clarifying changes to appointments, terms and membership that add legislative, executive, industry and regional representation and specify nonvoting members such as the Adjutant General and a representative from the Governor’s Office.

"The substitute bill makes a series of changes to clarify the operations composition of the commission and to provide additional transparency and accountability," Vice Chair Matthews said during the committee meeting. He outlined that legislative members would be selected by chamber leadership with bipartisan representation, that seven regional members would be established, and that nonvoting positions would include the Adjutant General, a Governor’s Office representative and other sector representatives.

The amendment also renames the Defense Commission the Ohio Defense and Space Commission and identifies a representative from Jobs Ohio’s chief investment officer or designee, the Ohio Chamber of Commerce, and the biotech sector among stakeholders. The committee agreed to the motion to amend "without objections," and the substitute was accepted.

What’s next: The fourth hearing on HB 292 concluded following the adoption of the substitute; the record in this session does not show a subsequent committee vote to advance the bill to the floor.